Non-nucleoside HIV-1 reverse transcriptase inhibitors, Part 7. Synthesis, antiviral activity, and 3D-QSAR investigations of novel 6-(1-naphthoyl) HEPT analogues. 2006

Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
Department of Chemistry, Fudan University, Shanghai 200433, People's Republic of China.

A series of novel 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) analogues bearing a 6-(1-naphthoyl) group of non-nucleoside human immunodeficiency virus (HIV) reverse transcriptase inhibitors were synthesized and evaluated for their activity against HIV-1 and HIV-2. It was found that most of these compounds showed good activity against HIV-1. Among them, compound 5-isopropyl-6-(1-naphthoyl)-1-[(2E)-3-phenylallyl]-2,4-pyrimidinedione (23) displayed the greatest inhibitory potency (IC(50)=0.14 muM), which is about 35-fold more active than HEPT and DDI. To rationalize the relationships between structure and activity of these novel compounds, a three-dimensional quantitative structure-activity relationship (3D-QSAR) model was also generated. The results provided a tool for guiding the further design of more potent antiviral agents and for predicting the affinity of related compounds.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013941 Thymine One of four constituent bases of DNA. 5-Methyluracil,5 Methyluracil
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
August 2005, Chemical & pharmaceutical bulletin,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
October 2005, Archiv der Pharmazie,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
September 2006, Bioorganic & medicinal chemistry,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
August 2006, Journal of enzyme inhibition and medicinal chemistry,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
April 2002, Journal of computer-aided molecular design,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
January 2012, Current medicinal chemistry,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
July 1996, Journal of medicinal chemistry,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
June 2012, Organic and medicinal chemistry letters,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
July 2003, Chemical & pharmaceutical bulletin,
Lei Ji, and Fen-Er Chen, and Xiao-Qing Feng, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
April 2012, Journal of molecular modeling,
Copied contents to your clipboard!